X-linked sideroblastic anemia and spinocerebellar ataxia

X-linked sideroblastic anemia and spinocerebellar ataxia (XLSA/A), also known as ASAT (anemia, sideroblastic, and spinocerebellar ataxia), is a rare genetic disorder caused by mutations in the ABCB7 gene located on the X chromosome. This gene encodes a mitochondrial transporter protein involved in iron-sulfur cluster biogenesis and iron homeostasis. The condition primarily affects males and is characterized by the combination of a blood disorder (sideroblastic anemia) and a progressive neurological condition (spinocerebellar ataxia). The sideroblastic anemia is typically mild to moderate, with the hallmark finding of ring sideroblasts in the bone marrow — abnormal red blood cell precursors with iron-laden mitochondria encircling the nucleus. The neurological features include cerebellar ataxia, which manifests as difficulties with coordination, balance, and gait. Patients may experience unsteady walking, impaired fine motor skills, and dysarthria (slurred speech). The ataxia is typically nonprogressive or slowly progressive. The anemia component involves ineffective erythropoiesis, and blood tests may show elevated free erythrocyte protoporphyrin levels. Female carriers are generally unaffected or may show very mild hematological abnormalities. Treatment is primarily supportive. Pyridoxine (vitamin B6) supplementation has been tried, as it is effective in some other forms of sideroblastic anemia, but response in XLSA/A is variable and often limited. Blood transfusions may be necessary in cases of more severe anemia, and iron chelation therapy may be required if iron overload develops. Physical therapy and rehabilitation can help manage the ataxia symptoms. There is currently no curative treatment available for this condition.

Common questions about X-linked sideroblastic anemia and spinocerebellar ataxia